Literature DB >> 4037167

Self-reported pelvic inflammatory disease in the US: a common occurrence.

S O Aral, W D Mosher, W Cates.   

Abstract

Based on a nationally representative sample of American women of reproductive age, in 1982, one in seven reported having had pelvic inflammatory disease (PID). One in ten had received ambulatory care, and one in 25 were hospitalized for PID. A two-fold race differential was observed in self-reported history of PID. One in four Blacks compared to one in eight Whites reported having received treatment for this condition sometime in the past. The previous history of PID, especially in the older age groups, reflects the combined effect of secular trends in PID incidence and temporal changes in diagnostic and treatment practices.

Entities:  

Mesh:

Year:  1985        PMID: 4037167      PMCID: PMC1646364          DOI: 10.2105/ajph.75.10.1216

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Sexual and contraceptive experience of young unmarried women in the United States, 1976 and 1971.

Authors:  M Zelnik; J F Kantner
Journal:  Fam Plann Perspect       Date:  1977 Mar-Apr

2.  Frequency and distribution of salpingitis and pelvic inflammatory disease in short-stay hospitals in the United States.

Authors:  O G Jones; A A Zaidi; R K St John
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

3.  Hospitalizations for pelvic inflammatory disease. Epidemiology and trends in the United States, 1975 to 1981.

Authors:  A E Washington; W Cates; A A Zaidi
Journal:  JAMA       Date:  1984-05-18       Impact factor: 56.272

Review 4.  Economic consequences of pelvic inflammatory disease in the United States.

Authors:  J W Curran
Journal:  Am J Obstet Gynecol       Date:  1980-12-01       Impact factor: 8.661

5.  Sexual activity, contraceptive use and pregnancy among metropolitan-area teenagers: 1971-1979.

Authors:  M Zelnik; J F Kantner
Journal:  Fam Plann Perspect       Date:  1980 Sep-Oct

6.  Fertility and family planning in the 1970s: the National Survey of Family Growth.

Authors:  W D Mosher
Journal:  Fam Plann Perspect       Date:  1982 Nov-Dec

7.  Pelvic inflammatory disease: incidence and trends in private practice.

Authors:  J H Blount; G H Reynolds; R J Rice
Journal:  MMWR CDC Surveill Summ       Date:  1983

8.  Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease.

Authors:  D E Moore; L R Spadoni; H M Foy; S P Wang; J R Daling; C C Kuo; J T Grayston; D A Eschenbach
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

9.  Gonorrhea in the United States: 1967-1979.

Authors:  A A Zaidi; S O Aral; G H Reynolds; J H Blount; O G Jones; R R Fichtner
Journal:  Sex Transm Dis       Date:  1983 Apr-Jun       Impact factor: 2.830

10.  Unsuspected chronic pelvic inflammatory disease in the infertile female.

Authors:  D L Rosenfeld; S M Seidman; R A Bronson; G M Scholl
Journal:  Fertil Steril       Date:  1983-01       Impact factor: 7.329

View more
  8 in total

1.  Fecundity and infertility in the United States.

Authors:  W D Mosher
Journal:  Am J Public Health       Date:  1988-02       Impact factor: 9.308

2.  Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the United States, 1995 and 2006-2010.

Authors:  Jami S Leichliter; Anjani Chandra; Sevgi O Aral
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

3.  The impact of sexually transmitted diseases on minority populations.

Authors:  J S Moran; S O Aral; W C Jenkins; T A Peterman; E R Alexander
Journal:  Public Health Rep       Date:  1989 Nov-Dec       Impact factor: 2.792

4.  Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic study.

Authors:  R A Hahn; L S Magder; S O Aral; R E Johnson; S A Larsen
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

Review 5.  Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.

Authors:  Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen
Journal:  Am J Epidemiol       Date:  2016-12-09       Impact factor: 4.897

6.  Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.

Authors:  M Kosseim; A Ronald; F A Plummer; L D'Costa; R C Brunham
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

7.  Seroepidemiology of chlamydia in Costa Rica.

Authors:  K M Vetter; R C Barnes; M W Oberle; L Rosero-Bixby; J Schachter
Journal:  Genitourin Med       Date:  1990-06

Review 8.  Pelvic inflammatory disease: improving awareness, prevention, and treatment.

Authors:  Breanne B Das; Jocelyn Ronda; Maria Trent
Journal:  Infect Drug Resist       Date:  2016-08-19       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.